Counseling Women About Sexual Health Effects of Contraceptives

S Vegunta, LE Houston, NA Nicholson… - Journal of Women's …, 2024 - liebertpub.com
Background: Choosing a contraceptive method is a pivotal decision for patients, whereas
health care professionals (HCPs) face challenges in providing suitable recommendations …

[Retracted] Clinical Efficacy of Dienogest versus Levonorgestrel‐Releasing Intrauterine System for Adenomyosis

S Yang, Y Liu, J Wen, Y Sun… - … Based Complementary and …, 2022 - Wiley Online Library
Objective. The aim of this study is to evaluate the efficacy of dienogest versus levonorgestrel‐
releasing intrauterine system (LNG‐IUS) for the treatment of adenomyosis. Methods. In this …

Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center …

J Perelló-Capó, J Estadella-Tarriel, I Gich-Saladich… - Contraception, 2023 - Elsevier
Objective To assess the bleeding profiles of the levonorgestrel 13.5 mg intrauterine device
(LNG13. 5-IUD) and Nova T copper 380 mm 2 IUD (Cu380-IUD). Study design Single …

Caregiver goals and satisfaction for menstrual suppression in adolescent females with developmental disabilities: A prospective cohort study

EM Buyers, KJ Hutchens, A Kaizer, SM Scott… - Disability and Health …, 2023 - Elsevier
Background Adolescents with developmental disabilities and their caregivers often seek
menstrual management. Caregivers frequently serve as medical decision-makers, and little …

Early discontinuation of long-acting reversible contraceptives methods and its associated factors in Hosanna town, central Ethiopia: a cross-sectional study

AD Bande, TB Handiso, HW Hanjelo, BH Jena - Scientific Reports, 2024 - nature.com
Long-acting reversible contraceptive (LARC) method use is an ideal strategy for longer
protection against unintended pregnancies, unsafe abortions, maternal morbidities, and …

The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS)

T Römer, AK Frenz, S Dietrich-Ott, A Fiedler - Archives of Gynecology and …, 2024 - Springer
Purpose The Kyleena™ Satisfaction Study (KYSS) provided the first data on 19.5 mg
levonorgestrel-releasing intrauterine system (LNG-IUS-19.5 mg) use in routine clinical …

Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z‐CAN) in Puerto Rico, 2016–2020

LB Zapata, K Kortsmit, KM Curtis… - Studies in Family …, 2024 - Wiley Online Library
Abstract The Zika Contraception Access Network (Z‐CAN) provided access to high‐quality
client‐centered contraceptive services across Puerto Rico during the 2016–2017 Zika virus …

Long-acting family planning switching and associated factors among revisit women in Toke Kutaye district of West Shoa Zone, Oromia Region public health facilities …

F Teshoma, EG Tefera, T Girma, MT Ragasa… - BMC Women's …, 2023 - Springer
Background Switching from a long-acting family planning (LAFP) method to another could
lead to an unintended pregnancy. However, the proportions of LAFP method switching and …

Contraceptives Association with Vaginal Microbiome and RTI: A Cross-Sectional Survey in Females of Jammu and Kashmir, India

C Chopra, D Sharma, V Kumar, I Bhushan - Indian Journal of Microbiology, 2024 - Springer
The present study aimed to examine the impacts of use of various contraceptive methods on
vaginal microbiome and reproductive tract infections (RTI) in females. A cross-sectional …

Descriptive study of the real-world, long-term cost estimates and duration of use for hormonal and nonhormonal intrauterine devices using US commercial insurance …

BT Nguyen, K Heyrana, R Ohsfeldt, A Johnston… - Journal of Managed …, 2023 - jmcp.org
BACKGROUND: Intrauterine devices (IUDs) have comparable efficacy to permanent
surgical contraceptive methods; however, long-term costs are infrequently considered …